Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate for non-symptomatic bone metastases in breast cancer
NCT00130494Phase 3Terminated
- Sponsor
- GEICAM
- Start
- Aug 2002
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in breast cancer, sponsored by GEICAM. Started Aug 2002; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00130494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130494.